1 / 10

Omega 3 Fatty Acids in Parenteral Nutrition

Omega 3 Fatty Acids in Parenteral Nutrition. Erin Buehler Lauryn Whitfield. Background. Most patients, especially critically ill, experience inflammation due to trauma or disease When oral intake or enteral feeding is not tolerated, patients may be placed on parenteral nutrition

lemuel
Download Presentation

Omega 3 Fatty Acids in Parenteral Nutrition

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Omega 3 Fatty Acids in Parenteral Nutrition Erin Buehler Lauryn Whitfield

  2. Background • Most patients, especially critically ill, experience inflammation due to trauma or disease • When oral intake or enteral feeding is not tolerated, patients may be placed on parenteral nutrition • Currently, the majority or parenteral solutions use safflower/soybean oil as a source of lipids, both containing high amounts of omega-6 polyunsaturated fatty acids

  3. Lipids in Parenteral Nutrition Disadvantages Advantages Provide energy and cellular building blocks Decreases risk of hyperglycemia Provides fat soluble vitamins Precursors to metabolically pertinent prostaglandins and eicosanoids • Elevate triglycerides: bypasses the lymphatic system

  4. Omega 6 vs. Omega 3 Fatty Acids Omega- 6 PUFA Omega-3 PUFA Anti-inflammatory Promote hemodynamic stability Quickly incorporated into immune cell membranes Increase stability and fluidity of the cell membrane Less thrombogenic effects Better T-cell immune function • Pro-inflammatory • Precursors of inflammatory mediators: leukotrienes and prostaglandins

  5. Critically Ill • May decrease length of hospital stay • Does not decrease mortality rates • In a study with an omega-3 to omega-6 ratio of 1:2, no statistically significant differences between length of stay, nosocomial infections, duration of mechanical ventilation, and inflammatory markers

  6. Colorectal Cancer • Decreases tumor protein synthesis and inhibits tumor growth • In one study, a statistically significant decrease in interleukin-6 and TNF-alpha levels were found • Some studies do not show the same effects in all cancers

  7. Parenteral Nutrition Associated Liver Disease • Ectopic fat deposits are common with long term use of parenteral nutrition • Omega-3 fatty acids can prevent or correct these complications • The appropriate ratio is still undetermined • Decreases liver availability of fatty acids for VLDL synthesis and secretion

  8. Other Conditions Spinal Cord Injuries General Surgery Inflammation post surgery is partly due to proinflammatory mediators (leukotrienes and prostaglandins) Omega-3 fatty acids counteract these effects Decreases mortality rates • Mouse study • Less cell death in the spinal cord • Improved locomotor performance during recovery time • Arachidonic acid is detrimental after injury, but omega-3 fatty acids can inhibit the action of AA

  9. Conclusions • General consensus among studies that use of omega-3 FA in PN produces no harmful effects • Use has shown to be beneficial in various disease states/conditions • Currently, there is no appropriate ratio determined • Should FDA approve use of omega-3 FA in PN?

  10. Areas for Future Research • More randomized controlled trials with larger samples and longer durations should be conducted to determine the appropriate ratio of omega-3:omega-6 FA • More research on the efficacy of omega-3 in PN in the critically ill

More Related